Financial Summary (All financials)
In millions, except per share items | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 |
Revenues | 57.0 | 56.8 | 46.3 | 34.4 | 32.5 | 35.9 | 22.3 |
Revenue growth | 0.3% | 22.7% | 34.5% | 5.9% | -9.5% | 61.4% | |
Cost of goods sold | 32.2 | 30.2 | 25.0 | 19.7 | 18.0 | 20.3 | 11.5 |
Gross profit | 24.8 | 26.6 | 21.3 | 14.7 | 14.5 | 15.7 | 10.7 |
Gross margin | 43.6% | 46.9% | 46.0% | 42.8% | 44.6% | 43.6% | 48.2% |
Selling, general and administrative | 25.4 | 23.1 | 18.5 | 15.5 | 36.2 | 22.0 | 10.5 |
Research and development | 4.8 | 4.7 | 2.8 | 4.9 | 3.0 | 5.2 | 2.2 |
EBIT | -6.8 | -2.2 | -1.2 | -5.7 | -26.6 | -14.4 | -3.8 |
EBIT margin | -11.9% | -4.0% | -2.6% | -16.5% | -81.8% | -40.2% | -17.2% |
Pre-tax income | -6.7 | -9.3 | -3.6 | -6.3 | -65.8 | -17.4 | -3.8 |
Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Tax rate | | | 0.0% | 0.0% | 0.0% | | |
Net income | -6.8 | -9.5 | -5.0 | -9.5 | -92.4 | -17.4 | -3.9 |
Net margin | -11.9% | -16.7% | -10.7% | -27.5% | -284.0% | -48.5% | -17.4% |
|
Diluted EPS | ($153.54) | ($220.29) | ($116.69) | ($221.67) | ($2,678.74) | ($928.48) | ($206.40) |
Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|